TISSOMICS™ is a drug discovery and development approach combining genomics and proteomics with histological, pathological and clinical data derived from normal and diseased tissue.

“Clinical Trial on a Chip”

By combining TISSOMICS™ with tissue microarray (TMA) technology, entire patient cohorts can be analyzed for multiple targets and biomarkers in a high-throughput format.

For more information on TISSOMICS™ and its application in validation of drug targets and biomarkers, please contact us .

TISSOMICS™ is a registered trademark of ORIDIS Biomarkers